Chronic Lymphocytic Leukemia Requires BCL2 to Sequester Prodeath BIM, Explaining Sensitivity to BCL2 Antagonist ABT-737
Journal of Clinical Investigation - United States
doi 10.1172/jci28281
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 2, 2007
Authors
Publisher
American Society for Clinical Investigation